In their study, in comparison to the MCF7, Bcap-37, or SK-BR-3 cancer cell lines, which exhibited low levels of LIN28 expression, the T47D cancer cell line, which expresses LIN28 abundantly, was more resistant to paclitaxel. This evidence concerns the gene LIN28A and cancer.